Archive | SIRION Biotech GmbH

Page 3 of 6
SIRION brings viral vector expertise to BioFIT 2020 virtual event
SIRION brings viral vector expertise to BioFIT 2020 virtual event Learn More >
SIRION Biotech licenses LentiBOOST™ Technology to Mustang Bio for development of XSCID gene therapy
SIRION Biotech licenses LentiBOOST™ Technology to Mustang Bio for development of XSCID gene therapy Learn More >
Bavaria supports SIRION in development of AAV-delivered protective antibodies against coronaviruses
Bavaria supports SIRION in development of AAV-delivered protective antibodies against coronaviruses Learn More >
SIRION Biotech defies COVID-19 to achieve 26% growth for first half 2020
SIRION Biotech defies COVID-19 to achieve 26% growth for first half 2020 Learn More >
SIRION wins Gold Stevie business award after reporting record growth and profits
SIRION wins Gold Stevie business award after reporting record growth and profits Learn More >
47548SIRION Biotech Viral Vector Engineering
SIRION Biotech Viral Vector Engineering Learn More >
47372SIRION adenovirus vector services
SIRION adenovirus vector services Learn More >
47189SIRION lentiviral vectors for stable gene overexpression or knowdown
SIRION lentiviral vectors for stable gene overexpression or knowdown Learn More >
SIRION licenses innovative LentiBOOST™ technology for CAR-T medicines development
SIRION licenses innovative LentiBOOST™ technology for CAR-T medicines development Learn More >
47009SIRION LentiBOOST™ non-cytotoxic transduction enhancer for lentiviral vectors
SIRION LentiBOOST™ non-cytotoxic transduction enhancer for lentiviral vectors Learn More >
SIRION Biotech returns to DG-GT gene therapy meeting
SIRION Biotech returns to DG-GT gene therapy meeting Learn More >
SIRION Biotech bringing advanced viral vector technologies to SFTCG Lyon
SIRION Biotech bringing advanced viral vector technologies to SFTCG Lyon Learn More >
Page 3 of 6